Table 2.
VAS-discomfort ratings.
| UP1306 | Glucosamine and chondroitin combination | Placebo | p value | |||
|---|---|---|---|---|---|---|
| All three products | UP1306 versus G&C | UP1306 versus placebo | ||||
| 24 hours | ||||||
| Change from baseline to day 84 | −3.47 ± 1.98 (43) | −3.32 ± 2.31 (44) | −3.49 ± 2.66 (41) | 0.935 | 0.922 | 0.953 |
| −4 (−8–1) | −3 (−7–3) | −4 (−8–3) | ||||
| p < 0.001∗ | p < 0.001∗ | p < 0.001∗ | ||||
|
| ||||||
| First week | ||||||
| change from baseline to day 6 | −1.14 ± 1.87 (42) | −1.16 ± 1.52 (44) | −1.37 ± 1.85 (41) | 0.811 | 0.879 | 0.610 |
| −1 (−5–3) | −1 (−5–1) | −1 (−6–2) | ||||
| p < 0.001∗ | p < 0.001∗ | p < 0.001∗ | ||||
|
| ||||||
| Past 7 days | ||||||
| change from baseline to week 12 | −3.49 ± 2.10 (43) | −3.09 ± 2.52 (44) | −3.49 ± 2.63 (41) | 0.680 | 0.582 | 0.902 |
| −4 (−8–1) | −3 (−7–3) | −4 (−8–1) | ||||
| p < 0.001∗ | p < 0.001∗ | p < 0.001∗ | ||||
∗ p < .05, the value is significant.